Home
/
KORU Medical Systems, Inc.
/
Financials
/
Quarterly
KORU Medical Systems, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that KORU Medical Systems, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$10.40M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$10.19M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$9.64M
May 7, 2025
Q3
2025
Sep 30, 2024
$8.18M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$8.43M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$8.20M
May 7, 2025
Q3
2024
Sep 30, 2023
$7.00M
Nov 13, 2024
Q2
2024
Jun 30, 2023
$6.94M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$7.39M
May 1, 2024
Q3
2023
Sep 30, 2022
$7.76M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$6.55M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$6.24M
May 4, 2023
Q3
2022
Sep 30, 2021
$6.04M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$5.53M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$5.43M
May 4, 2022
Q3
2021
Sep 30, 2020
$6.08M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$7.71M
Aug 11, 2021
Q1
2021
Mar 31, 2020
$6.33M
May 12, 2021
Q3
2020
Sep 30, 2019
$6.62M
Nov 12, 2020
Q2
2020
Jun 30, 2019
$5.35M
Aug 5, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$3.85M
Nov 3, 2017
Q2
2017
Jun 30, 2017
$3.83M
Aug 4, 2017
Q2
2017
Mar 31, 2017
$1.51M
Aug 4, 2017
Q3
2017
Nov 30, 2016
$3.19M
Jan 5, 2017
Q3
2017
Sep 30, 2016
$3.22M
Nov 3, 2017
Q2
2017
Aug 31, 2016
$3.15M
Oct 7, 2016
Q2
2017
Jun 30, 2016
$2.80M
Aug 4, 2017
Q1
2017
May 31, 2016
$2.99M
Jun 30, 2016
Q2
2017
Mar 31, 2016
$1.28M
Aug 4, 2017
Q3
2017
Nov 30, 2015
$3.14M
Jan 5, 2017
Q2
2017
Aug 31, 2015
$3.17M
Oct 7, 2016
Q1
2017
May 31, 2015
$2.63M
Jun 30, 2016
Q3
2015
Nov 30, 2014
$2.66M
Jan 8, 2016
Q2
2016
Aug 31, 2014
$2.50M
Oct 2, 2015
Q1
2016
May 31, 2014
$2.64M
Jul 10, 2015
Q3
2015
Nov 30, 2013
$2.18M
Jan 14, 2015
Q2
2015
Aug 31, 2013
$2.01M
Oct 15, 2014
Q1
2015
May 31, 2013
$1.88M
Jul 15, 2014
Q3
2013
Nov 30, 2012
$2.07M
Jan 14, 2014
Q2
2013
Aug 31, 2012
$1.95M
Oct 15, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($778.0K)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($206.9K)
Aug 6, 2025
Q3
2025
Jun 30, 2025
($206.9K)
Nov 12, 2025
Q1
2025
Mar 31, 2025
($1.17M)
May 7, 2025
Q3
2025
Mar 31, 2025
($1.17M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($1.17M)
Aug 6, 2025
Q3
2025
Sep 30, 2024
($1.58M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($988.7K)
Aug 6, 2025
Q3
2025
Jun 30, 2024
($988.7K)
Nov 12, 2025
Q3
2025
Mar 31, 2024
($1.94M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($1.94M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($1.94M)
May 7, 2025
Q3
2024
Sep 30, 2023
($1.37M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.50M)
Aug 7, 2024
Q3
2024
Jun 30, 2023
($2.50M)
Nov 13, 2024
Q1
2024
Mar 31, 2023
($2.41M)
May 1, 2024
Q2
2024
Mar 31, 2023
($2.41M)
Aug 7, 2024
Q3
2024
Mar 31, 2023
($2.41M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
($1.23M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($2.92M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($867.7K)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($312.7K)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($1.25M)
May 7, 2025
Q3
2025
Sep 30, 2024
($1.70M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.19M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($1.96M)
May 7, 2025
Q3
2024
Sep 30, 2023
($1.79M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.22M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($3.06M)
May 1, 2024
Q3
2023
Sep 30, 2022
($1.53M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($3.61M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($3.13M)
May 4, 2023
Q3
2022
Sep 30, 2021
($1.32M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($1.38M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($2.21M)
May 4, 2022
Q3
2021
Sep 30, 2020
$358.8K
Nov 10, 2021
Q2
2021
Jun 30, 2020
($1.03M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
$582.8K
May 12, 2021
Q3
2020
Sep 30, 2019
$824.5K
Nov 12, 2020
Q2
2020
Jun 30, 2019
$35.9K
Aug 5, 2020